In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms

The in vitro activity of the trinem sanfetrinem (formerly GV104326) (GV) was compared with that of vancomycin, ampicillin, and/or nafcillin against 287 gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and multiresistant enterococci, by the agar and microbroth dilution methods. GV demonstrated 2 to 16 times more activity than ampicillin and nafcillin against the majority of these organisms. The MIC range of GV was 16 to 64 micrograms/ml for 19 Enterococcus faecium strains that were highly resistant to ampicillin (ampicillin MIC range, 64 to 512 micrograms/ml) and vancomycin resistant and 0.25 to 32 micrograms/ml for resistant Rhodococcus spp. Similar activities (+/-1 dilution) were observed by either the agar or the broth microdilution method. GV demonstrated bactericidal activity against a beta-lactamase-producing Enterococcus faecalis strain and against two methicillin-susceptible Staphylococcus aureus strains in 10(5)-CFU/ml inocula. Synergy between GV and gentamicin was observed against an E. faecalis strain that lacked high-level gentamicin resistance. The activity of GV suggests this compound warrants further study.

[1]  K. Bush.  Characterization of beta-lactamases , 1989, Antimicrobial Agents and Chemotherapy.

[2]  A. Efstratiou,et al.  Vancomycin-resistant leuconostocs, lactobacilli and now pediococci. , 1987, Journal of Hospital Infection.

[3]  Y. Coovadia,et al.  Meningitis caused by vancomycin-resistant Leuconostoc sp , 1987, Journal of clinical microbiology.

[4]  R. Moellering.  Emergence of Enterococcus as a significant pathogen. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  G. Wormser,et al.  LEUCONOSTOC, AN EMERGING VANCOMYCIN-RESISTANT PATHOGEN , 1987, The Lancet.

[6]  F. Soriano,et al.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents , 1995, Antimicrobial agents and chemotherapy.

[7]  T. Yokota,et al.  Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus , 1985, Antimicrobial Agents and Chemotherapy.

[8]  B. Murray.  The life and times of the Enterococcus , 1990, Clinical Microbiology Reviews.

[9]  L. Rice,et al.  β-Lactamase-producing enterococci , 1995 .

[10]  T. Nicas,et al.  Activity of glycopeptides against vancomycin-resistant gram-positive bacteria , 1989, Antimicrobial Agents and Chemotherapy.

[11]  J. Waitz.  Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .

[12]  B. Murray.  New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. , 1991, The Journal of infectious diseases.

[13]  P. Nordmann,et al.  Correlation between antibiotic resistance, phage-like particle presence, and virulence in Rhodococcus equi human isolates , 1994, Journal of clinical microbiology.

[14]  F. Malouin,et al.  Modification of penicillin-binding proteins as mechanisms of beta-lactam resistance , 1986, Antimicrobial Agents and Chemotherapy.

[15]  C. Branger,et al.  Vancomycin-resistant streptococci or Leuconostoc sp , 1985, Antimicrobial Agents and Chemotherapy.

[16]  S. Tailor,et al.  Enterococcus, an Emerging Pathogen , 1993, The Annals of pharmacotherapy.

[17]  K. Singh,et al.  Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  G. Satta,et al.  Overproduction of a low-affinity penicillin-binding protein and high-level ampicillin resistance in Enterococcus faecium , 1994, Antimicrobial Agents and Chemotherapy.

[19]  C. Hackbarth,et al.  Methicillin-resistant staphylococci: genetics and mechanisms of resistance , 1989, Antimicrobial Agents and Chemotherapy.

[20]  J. Hamilton-miller,et al.  WORLD-WIDE ANTIBIOTIC RESISTANCE IN METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS , 1989, The Lancet.

[21]  A. Tomasz,et al.  Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus , 1984, Journal of bacteriology.

[22]  S. M. Hammond,et al.  In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria , 1994, Antimicrobial Agents and Chemotherapy.

[23]  R. Moellering,et al.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies. , 1971, The Journal of laboratory and clinical medicine.

[24]  A. Tomasz,et al.  Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance. , 1986, The Journal of infectious diseases.

[25]  B. Murray,et al.  Beta-lactamase-producing enterococci , 1992, Antimicrobial Agents and Chemotherapy.

[26]  K. Hiramatsu,et al.  TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus , 1995, Antimicrobial agents and chemotherapy.

[27]  G. Wormser,et al.  Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit , 1994, Antimicrobial Agents and Chemotherapy.

[28]  M. Ferraro,et al.  In vitro activities of daptomycin and other antimicrobial agents against vancomycin-resistant gram-positive bacteria , 1989, Antimicrobial Agents and Chemotherapy.

[29]  M. Zervos,et al.  Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. , 1987, Annals of internal medicine.

[30]  H. Neu,et al.  The Crisis in Antibiotic Resistance , 1992, Science.

[31]  A. Tomasz,et al.  New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity , 1989, Antimicrobial Agents and Chemotherapy.

[32]  L. Rubin,et al.  Infection with vancomycin-resistant "streptococci" due to Leuconostoc species. , 1988, The Journal of infectious diseases.